These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25488879)

  • 21. Economic evaluation of interventions for problem drinking and alcohol dependence: cost per QALY estimates.
    Mortimer D; Segal L
    Alcohol Alcohol; 2005; 40(6):549-55. PubMed ID: 16103034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuropharmacoeconomics].
    Chiu HC
    Acta Neurol Taiwan; 2004 Jun; 13(2):87-96. PubMed ID: 15478681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
    Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
    Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving value measurement in cost-effectiveness analysis.
    Ubel PA; Nord E; Gold M; Menzel P; Prades JL; Richardson J
    Med Care; 2000 Sep; 38(9):892-901. PubMed ID: 10982111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Economic evaluation of targeted cancer therapy].
    Ikeda S
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):967-70. PubMed ID: 23986036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on cost-value analysis.
    Østerdal LP
    Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there an alternative to quality-adjusted life years for supporting healthcare decision making?
    Beresniak A; Dupont D
    Expert Rev Pharmacoecon Outcomes Res; 2016 Jun; 16(3):351-7. PubMed ID: 27139424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resource allocation, social values and the QALY: a review of the debate and empirical evidence.
    Schwappach DL
    Health Expect; 2002 Sep; 5(3):210-22. PubMed ID: 12199660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measures of efficiency in healthcare: QALMs about QALYs?
    Schlander M
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):214-26. PubMed ID: 20608250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective.
    Ademi Z; Gloy V; Glinz D; Raatz H; Van Stiphout J; Bucher HC; Schwenkglenks M
    Swiss Med Wkly; 2016; 146():w14382. PubMed ID: 27922167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life satisfaction, QALYs, and the monetary value of health.
    Huang L; Frijters P; Dalziel K; Clarke P
    Soc Sci Med; 2018 Aug; 211():131-136. PubMed ID: 29935403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concerns for the worse off: fair innings versus severity.
    Nord E
    Soc Sci Med; 2005 Jan; 60(2):257-63. PubMed ID: 15522483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How much does the society want to pay?].
    Norheim OF
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):303. PubMed ID: 12640893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.